About Dr. Singh
Dr. Purva Singh joined Hospital for Special Surgery in November 2016. Currently, she is working on two research projects. One study is aimed at understanding the effect of changes in DNA methylation on osteoarthritis progression and identifying functional relationship that lead to changes in differential gene expression. Another research project she handles is focused on investigating contributions of cytokines and adipokines released by adipose tissue surrounding the joint in initiation and progression of osteoarthritis. Using next generation sequencing and other biochemical assays, the overall goal of her research is to identify targets for the treatment of osteoarthritis.
Dr. Singh received her BSc and MSc in Microbiology from Devi Ahilya Vishwa Vidyalaya (D.A.V.V), Indore, India. She earned her PhD in Biomedical Sciences from Albany Medical College, Albany, NY. Her doctoral research was focused on understanding role of cell surface receptor (integrins) in cutaneous wound healing. Dr. Singh later joined Princeton University as postdoctoral fellow, where her research was focused on studying the effect of extracellular matrix on stem cell renewal and differentiation with emphasis on differentiation towards chondrogenic lineage.
Departments
Credentials
Appointments
Senior Research Associate, Hospital for Special Surgery
Languages
English
Publications by Dr. Singh
For all publications, please see the PubMed listing.
Industry Relationships
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Research staff at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however, HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists Research staff collaborations with outside companies if the Research staff member received any payment during the prior year or expects to receive any payment in the next year. The disclosures are based on information provided by the Research staff and other sources and are updated regularly. Current ownership interests and leadership positions are also listed. Further information may be available on individual company websites.
As of November 07, 2024, Dr. Singh reported no relationships with healthcare industry.
By disclosing the collaborations of HSS Research staff with industry on this website, HSS and its Research staff make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit payment of royalties on products developed by him/her that are used on patients at HSS.